Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$138,736,578
New position
Shares Held
1,930,651
first reported quarter
Ownership
0.467%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#38
of 1,408 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 89%
Shared 0%
None 11%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BRANDES INVESTMENT PARTNERS, LP holds $384,167,076 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (36.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,930,651 | $138,736,578 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
2,051,060 | $96,953,605 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
2,972,036 | $73,141,804 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
4,539,347 | $72,765,732 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4,742 | $2,569,357 |
All Filings in ZTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,736,578 | 1,930,651 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||